The number of pesticides and other potentially dangerous toxins is increasing constantly, posing special analytical challenges. It is crucial to screen food for the presence of toxins accurately and reliably, and to ensure the safety and quality of nutrition. To do so, we have to have the knowledge about how to deal with several hundreds of different poisonous matters. Bruker delivers solutions that meet the requirements for the identification and quantification of toxicants during the screening of each sample. Bruker’s high-performance TOF-MS is ideally suited for all screening tasks. And Bruker’s SCION series sets a new industry standard for GC-MS. Their easy usability, sensitivisty, robustness and performance make SCION solutions a major technology in food safety.
By Bruker Corporation based in Billerica, MASSACHUSETTS (USA).
Context & Challenges Globally, the wastewater treatment is the first public health issue. Urban development leads to urbanization near waste water treatment plant and extension of sewerage network. These aspects induce to an augmentation of sulfur compounds (H2S, mercaptans and sulfides) which are very corrosive, odorant and toxic. To monitor this compounds online CHROMATOTEC® offers high meteorological solutions. To ensure the safety of operatives in the screening building/area of waste water treatment works an H2S analyzer has been installed in the main building to complement the protection provided by individual monitors. Chromatographic measurements show that other sulfurous compounds including Methylmercaptans are present in the air in addition to H2S.
By Chromatotec Group based in Val de Virvée, FRANCE.
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic leukemia.
By Aurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you